))
DerrellPorter_e.012
Manage episode 324091427 series 3006114
İçerik John Flavin tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan John Flavin veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Dr. Derrell Porter is a physician-entrepreneur with years of experience in the business of medicine, and one of the few experts with dual capabilities in developing and commercializing rapidly evolving cell therapies. Before founding his first startup, Cellevolve, Dr. Porter was the Head of Commercial at Atara Bio, a leader in off-the-shelf T-cell immunotherapy. Dr. Porter has held roles of increasing responsibility at three leading biopharmaceutical companies: Gilead, AbbVie, and Amgen.
Dr. Porter earned his MD from the University of Pennsylvania’s Perelman School of Medicine (where he was a Gamble Scholar) and an MBA from The Wharton School. He earned his BS in Neuroscience from the University of California, Los Angeles (UCLA). Additionally, he is on the boards of NASDAQ listed Passage Bio, a Philadelphia-based genetics medicine company, and a board member at Portal Innovations; he also serves as an Advisory Committee Member for the Penn School of Medicine.
Dr. Porter has such a unique background and set of experiences ranging from medical training and experience in commercializing drugs at large biopharma companies to the application of that knowledge in start-up settings.
63 bölüm
Paylaş
